P053. An Italian study on the actual cost/benefit of onabotulinumtoxinA (BT-A) in chronic migraine: preliminary results

The Journal of Headache and Pain

Poster Presentation

Edoardo Vicenzini¹  Alessandro Viganò¹  Vittorio Di Piero¹  Martina Squitieri¹  Barbara Petolicchio¹  Massimiliano Toscano¹ 

[1] Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy;

关键词: Migraine;    Pain Intensity;    Chronic Migraine;    Health Cost;    Attack Frequency;   

DOI  :  10.1186/1129-2377-16-S1-A112

来源: Springer

【 授权许可】

CC BY   
© Petolicchio et al. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.